Product Information
ZIPRASIDONE 20 MG/ML VIAL is a generic product labeled by Fosun Pharma USA Inc., priced at $21.8074 per EA under NDC 72266016042. Its NADAC has been published 68 times since Jun 18, 2025.
FDA first approved this application on Dec 26, 2019. Its Orange Book therapeutic-equivalence code is AP.
Strength
20 mg/mL
Manufacturer
Fosun Pharma USA Inc.NDC
72266016042
Classification
Generic
Dosage Form
INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Route
INTRAMUSCULAR
Effective Date
7/22/2026
Active Ingredients
ZIPRASIDONE MESYLATEApproval Type
Generic (ANDA)
FDA Application
ANDA211908FDA Approved
12/26/2019
TE Code
AP
On Market Since
10/27/2020
Pharmacological Classes
Price Statistics
The NADAC for ZIPRASIDONE 20 MG/ML VIAL has been published 68 times since Jun 18, 2025, and over the history we have for it it has risen 32.4%. The table below summarizes its recorded NADAC range and movement.
| Current price | $21.8074 per EA |
|---|---|
| All-time high | $24.0498 (Apr 15, 2026) |
| All-time low | $16.4680 (Jun 18, 2025) |
| 52-week high | $24.0498 |
| 52-week low | $17.9431 |
| Median price | $18.7008 |
| Average price | $20.1308 |
| Largest weekly change | +28.6% (Feb 18, 2026) |
| Weeks tracked | 68 |
| Tracking since | Jun 18, 2025 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Fosun Pharma USA Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Ziprasidone Mesylate market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Atypical Antipsychotic class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of ZIPRASIDONE 20 MG/ML VIAL?
The current National Average Drug Acquisition Cost (NADAC) for ZIPRASIDONE 20 MG/ML VIAL, manufactured by Fosun Pharma USA Inc., is $21.8074 per EA (NDC 72266016042), effective Sep 30, 2026.
How has the price of ZIPRASIDONE 20 MG/ML VIAL changed over time?
Over the history we have for it, the NADAC for ZIPRASIDONE 20 MG/ML VIAL has risen 32.4%. It has been tracked across 68 weekly CMS publications since Jun 18, 2025.
What are the highest and lowest recorded NADAC prices for ZIPRASIDONE 20 MG/ML VIAL?
Since Jun 18, 2025, the NADAC for ZIPRASIDONE 20 MG/ML VIAL has ranged from a low of $16.4680 (Jun 18, 2025) to a high of $24.0498 (Apr 15, 2026), with a median of $18.7008 per EA.
Are there cheaper alternatives to ZIPRASIDONE 20 MG/ML VIAL?
1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as ZIPRASIDONE 20 MG/ML VIAL in a comparable dosage form, but none are currently priced below it.
Who manufactures ZIPRASIDONE 20 MG/ML VIAL?
ZIPRASIDONE 20 MG/ML VIAL (NDC 72266016042) is labeled by Fosun Pharma USA Inc., and CMS classifies it as a generic product.